InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Longeveron Inc.

LGVN Clue Score27
United States Fiscal year ends December CIK 0001721484
$2.48 +4.64% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.48 −28.12% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Feb 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue5.6Operating income−3.8Net income−3.7Fiscal year 2021Revenue1.3 −76.8%Operating income−17.5Net income−17.0EPS, diluted−0.90Fiscal year 2022Revenue1.2 −6.4%Operating income−18.0Net income−18.8EPS, diluted−0.90Fiscal year 2023Revenue0.7 −42.0%Operating income−21.0Net income−21.4EPS, diluted−10.22Fiscal year 2024Revenue2.4 +237.4%Operating income−16.5Net income−16.0EPS, diluted−2.62Fiscal year 2025Revenue1.2 −49.9%Operating income−23.3Net income−22.7EPS, diluted−1.29
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 5.6 1.3 1.2 0.7 2.4 1.2
Growth −76.8% −6.4% −42.0% +237.4% −49.9%
Operating income −3.8 −17.5 −18.0 −21.0 −16.5 −23.3
Net income −3.7 −17.0 −18.8 −21.4 −16.0 −22.7
Growth
EPS, diluted n/a −0.90 −0.90 −10.22 −2.62 −1.29

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2020Gross margin32.4%Operating margin−67.1%Net margin−66.1%Free cash flow margin−44.3%Fiscal year 2021Gross margin45.2%Operating margin−1,336.6%Net margin−1,305.1%Free cash flow margin−763.1%Fiscal year 2022Gross margin40.7%Operating margin−1,476.5%Net margin−1,541.3%Free cash flow margin−1,189.7%Fiscal year 2023Gross margin31.2%Operating margin−2,966.0%Net margin−3,020.2%Free cash flow margin−2,722.6%Fiscal year 2024Gross margin78.8%Operating margin−690.7%Net margin−667.8%Free cash flow margin−607.1%Fiscal year 2025Gross margin67.0%Operating margin−1,942.2%Net margin−1,893.6%Free cash flow margin−1,575.5%
FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 32.4% 45.2% 40.7% 31.2% 78.8% 67.0%
Operating margin −67.1% −1,336.6% −1,476.5% −2,966.0% −690.7% −1,942.2%
Net margin −66.1% −1,305.1% −1,541.3% −3,020.2% −667.8% −1,893.6%
Free cash flow margin −44.3% −763.1% −1,189.7% −2,722.6% −607.1% −1,575.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−2.4Capital expenditure−0.1Free cash flow−2.5Fiscal year 2021Operating cash flow−9.6Capital expenditure−0.3Free cash flow−10.0Fiscal year 2022Operating cash flow−14.0Capital expenditure−0.6Free cash flow−14.5Fiscal year 2023Operating cash flow−19.0Capital expenditure−0.3Free cash flow−19.3Fiscal year 2024Operating cash flow−13.9Capital expenditure−0.7Free cash flow−14.5Fiscal year 2025Operating cash flow−18.6Capital expenditure−0.2Free cash flow−18.9
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −2.4 −9.6 −14.0 −19.0 −13.9 −18.6
Capital expenditure −0.1 −0.3 −0.6 −0.3 −0.7 −0.2
Free cash flow −2.5 −10.0 −14.5 −19.3 −14.5 −18.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2020Cash0.8Total debt0.3Net cash (debt)0.5Shareholders’ equity2.0Debt to equity0.16Fiscal year 2021Cash25.7Shareholders’ equity37.5Fiscal year 2022Cash10.5Shareholders’ equity20.5Fiscal year 2023Cash4.9Shareholders’ equity6.7Fiscal year 2024Cash19.2Shareholders’ equity21.9Fiscal year 2025Cash4.7Shareholders’ equity5.7
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.8 25.7 10.5 4.9 19.2 4.7
Total debt 0.3 n/a n/a n/a n/a n/a
Net cash (debt) 0.5 n/a n/a n/a n/a n/a
Shareholders’ equity 2.0 37.5 20.5 6.7 21.9 5.7
Debt to equity 0.16 n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
5.6 1.3 1.2 0.7 2.4 1.2
Growth −76.8% −6.4% −42.0% +237.4% −49.9%
3.8 0.7 0.7 0.5 0.5 0.4
1.8 0.6 0.5 0.2 1.9 0.8
Growth −67.7% −15.8% −55.5% +752.5% −57.4%
2.7 7.1 9.4 9.1 8.1 12.0
2.7 9.7 8.1 12.2 10.3 12.0
−3.8 −17.5 −18.0 −21.0 −16.5 −23.3
Growth
n/a n/a 0.0 0.0 0.0 0.0
−3.7 −17.0 −18.8 −21.4 −16.0 −22.7
Growth
Per share
n/a −0.90 −0.90 −10.22 −2.62 −1.29
n/a −0.90 −0.90 −10.22 −2.62 −1.29
Growth
n/a 18.9 21.0 2,173 9,411 17,577
n/a 18.9 21.0 2,173 9,411 17,577
Growth +10.9% +10,265.2% +333.0% +86.8%

† The diluted share count jumps at 2023 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 26.6% a year over five years.
  • Operating margin is down 1,875.1 points on five years ago, at -1,942.2%.
  • A net loss in 6 of 6 years on file.